The scope and impact of treatment of latent tuberculosis infection in the United States and Canada.
Moulding
Thomas
T
D000995:Antitubercular Agents / Q000627:therapeutic use*; D002170:Canada / Q000453:epidemiology; D006801:Humans; D018570:Risk Assessment; D014376:Tuberculosis / Q000188:drug therapy* / Q000453:epidemiology; D014481:United States / Q000453:epidemiology
D000995:Antitubercular Agents